• No results found

[PDF] Top 20 Synthetic biology for pharmaceutical drug discovery

Has 10000 "Synthetic biology for pharmaceutical drug discovery" found on our website. Below are the top 20 most common "Synthetic biology for pharmaceutical drug discovery".

Synthetic biology for pharmaceutical drug discovery

Synthetic biology for pharmaceutical drug discovery

... Abstract: Synthetic biology (SB) is an emerging discipline, which is slowly reorienting the field of drug ...turned pharmaceutical industries away from this rich source for human ...in ... See full document

18

Epigenetic assays for chemical biology and drug discovery

Epigenetic assays for chemical biology and drug discovery

... molecules that contain a conjugated system, i.e. a deloca- lized π-bond system which is usually attributed to alter- nating single and double bonds. When chromophores absorb ultraviolet (UV) and visible radiation, their ... See full document

19

The Success of Natural Products in Drug Discovery

The Success of Natural Products in Drug Discovery

... cellular biology and genomics not only increased the number of molecular targets but also demanded shorter drug discovery ...prompted pharmaceutical industries to look towards synthetic ... See full document

15

Natural Product in Drug Discovery: Back to Future

Natural Product in Drug Discovery: Back to Future

... years, Pharmaceutical industry research into natural products has declined, in part because of an emphasis on high-throughput screening of synthetic ...new drug approvals and impending loss of patent ... See full document

6

Technology Trends in Drug Discovery and Development: Implications for the Development of the Pharmaceutical Industry in Australia

Technology Trends in Drug Discovery and Development: Implications for the Development of the Pharmaceutical Industry in Australia

... the drug discovery and development process, its strengths have historically been concentrated in only a few of the ...medicine, biology and biotechnology and has developed a strong presence in ... See full document

29

Living GenoChemetics by hyphenating synthetic biology and synthetic chemistry in vivo

Living GenoChemetics by hyphenating synthetic biology and synthetic chemistry in vivo

... for drug discovery 1 , and there is much interest in the generation of analogs of such compounds in order to explore modes of action, determine structure-activity- relationships and improve bioavailability ... See full document

10

Trends in Biopharmaceutical Alliances for the Key Business Models

Trends in Biopharmaceutical Alliances for the Key Business Models

... large pharmaceutical companies in funding a great diversity of alliances, with both platform and drug discovery companies, is again consistent with the role expected of them as they adjust their ... See full document

11

Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development

Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development

... for drug testing, but are not amenable to physiological perfusion required by organ-like ...parallelized drug screening [6], multiwell culture systems are limited in terms of ...high-content drug ... See full document

5

Synthetic and Systems Biology Approach towards Designing Metabolic Bypass and Identifying Novel Enzymes for Cholesterol Lowering Drug Precursor (BTO) Biosynthesis from Crude Glycerol

Synthetic and Systems Biology Approach towards Designing Metabolic Bypass and Identifying Novel Enzymes for Cholesterol Lowering Drug Precursor (BTO) Biosynthesis from Crude Glycerol

... established synthetic metabolic pathways were implemented in higher plant Arabidopsis thaliana resulting into low production with 20 mg of BTO per gram of soil-grown plants (Abdel-Ghany et ...A synthetic ... See full document

7

Synthesis and Biological Evaluation of 4-Oxazolidinones and Dual JAK/TRPV-1 Inhibitors.

Synthesis and Biological Evaluation of 4-Oxazolidinones and Dual JAK/TRPV-1 Inhibitors.

... their synthetic analogs were found to have potent antimicrobial activity against methicillin- resistant Staphylococcus aureus (MRSA), a multidrug resistant (MDR) ... See full document

181

“COMPUTER-AIDED
                                    DRUG DESIGN - A NEW APPROACH IN DRUG DESIGN AND DISCOVERY” 
                            
                                Satyajit Dutta*, India.

“COMPUTER-AIDED DRUG DESIGN - A NEW APPROACH IN DRUG DESIGN AND DISCOVERY” Satyajit Dutta*, India.

... Pharmaceutical companies are always searching for new leads to develop into drug compounds. One search method is virtual high-throughput screening. In vHTS, protein targets are screened against databases of ... See full document

6

TECHNOLOGY TRANSFER IN PHARMACEUTICAL INDUSTRY: TRANSFER OF PROCESS FROM DEVELOPMENT TO COMMERCIALIZATION

TECHNOLOGY TRANSFER IN PHARMACEUTICAL INDUSTRY: TRANSFER OF PROCESS FROM DEVELOPMENT TO COMMERCIALIZATION

... New Drug Application; NDA in the USA and ...and Drug Administration; FDA, the Medicines and Healthcare products Regulatory Agency; MHRA in the UK and the European Agency for the Evaluation of Medicinal ... See full document

17

Continuous microflow photochemistry and its application in pharmaceutical drug discovery, development and production

Continuous microflow photochemistry and its application in pharmaceutical drug discovery, development and production

... 連続マイクロフロー型光化学反応と その創薬・医薬品開発/製造への応用 James Cook University, School of Pharmacy and Molecular Sciences, Townsville QLD 4811(Australia) Kobe University, Graduate School[.] ... See full document

11

Innovation in pharma sector: The impact of ipr (product patent) in Indian scenario: an overview

Innovation in pharma sector: The impact of ipr (product patent) in Indian scenario: an overview

... Also, pharmaceutical industry did not receive a significant input of foreign direct ...investment. Pharmaceutical multinationals maintained a low key presence in Indian market due to absence of product ... See full document

13

Synthetic biology, metaphors and responsibility

Synthetic biology, metaphors and responsibility

... entitled Synthetic Biology: Metaphors, Worldviews, Ethics and Law (Boldt, 2016a) and aims to assess social, ethical, and philosophical perspectives on synthetic biology beyond purely assessing ... See full document

13

SOLID STATE CRYSTALLINITY, AMORPHOUS STATE, AND ITS IMPLICATIONS IN THE PHARMACEUTICAL PROCESS

SOLID STATE CRYSTALLINITY, AMORPHOUS STATE, AND ITS IMPLICATIONS IN THE PHARMACEUTICAL PROCESS

... of pharmaceutical materials, the amorphous substances have many useful properties like higher solubility, dissolution rate, and better compression characteristics than corresponding ...standard ... See full document

11

Incremental learning of the different dynamic signatures of mitochondrial movement in drug discovery and system biology

Incremental learning of the different dynamic signatures of mitochondrial movement in drug discovery and system biology

... After the assay has been set up and the interaction of the cells with drug and proteins has been started it is not quite clear what the concepts of the different phases of a cell are. This has to be learnt during ... See full document

9

COMPUTER‐AIDED DOCKING: AN INVALUABLE TOOL
IN DRUG DISCOVERY AND MOLECULAR BIOLOGY

COMPUTER‐AIDED DOCKING: AN INVALUABLE TOOL IN DRUG DISCOVERY AND MOLECULAR BIOLOGY

... proteins is known. Our goal of this study was to explore the feasibility of four different docking approaches: (AutoDock/Vina, GOLD, FRED and FlexX) for our target ASMT and to find out the lead compound. We compared the ... See full document

6

3 D Printing a Revolutionary Approach in Medicinal Science- Review

3 D Printing a Revolutionary Approach in Medicinal Science- Review

... 3 D printing has to raise biosynthesis of artificial organs to a new height. Medical uses for 3D printing are categories into, tissue and organ fabrication; synthesis of customized prosthetics, implants, and anatomical ... See full document

11

Precision medicine as a promising tool to empower research in healthcare industry

Precision medicine as a promising tool to empower research in healthcare industry

... [23] Vertex, Investor Relations, News & Events, CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease. ... See full document

6

Show all 10000 documents...